Activin and Inhibin

IMP-1088 is a potent human N-myristoyltransferases NMT1 and NMT2 dual inhibitor with IC 50 s of &lt:1 nM for HsNMT1 and HsNMT2. IMP-1088 has a K d of &lt:210 pM for HsNMT1. IMP-1088 efficiently blocks rhinovirus replication by blocking rhinovirus

IMP-1088 is a potent human N-myristoyltransferases NMT1 and NMT2 dual inhibitor with IC 50 s of &lt:1 nM for HsNMT1 and HsNMT2. IMP-1088 has a K d of &lt:210 pM for HsNMT1. IMP-1088 efficiently blocks rhinovirus replication by blocking rhinovirus

IMP-1088 is a potent human N-myristoyltransferases NMT1 and NMT2 dual inhibitor with IC 50 s of &lt:1 nM for HsNMT1 and HsNMT2. IMP-1088 has a K d of &lt:210 pM for HsNMT1. IMP-1088 efficiently blocks rhinovirus replication by blocking rhinovirus

IMP-1088 is a potent human N-myristoyltransferases NMT1 and NMT2 dual inhibitor with IC 50 s of &lt:1 nM for HsNMT1 and HsNMT2. IMP-1088 has a K d of &lt:210 pM for HsNMT1. IMP-1088 efficiently blocks rhinovirus replication by blocking rhinovirus

Implitapide (AEGR 427) is a microsomal triglyceride transfer protein ( MTP ) inhibitor.In VitroImplitapide suppresses MTP activity using a recombinant human form complexed with protein disulphide isomerase (IC 50 =10 nM) and inhibit secretion of

Implitapide (AEGR 427) is a microsomal triglyceride transfer protein ( MTP ) inhibitor.In VitroImplitapide suppresses MTP activity using a recombinant human form complexed with protein disulphide isomerase (IC 50 =10 nM) and inhibit secretion of

IMT1 is a first-in-class specific and noncompetitive human mitochondrial RNA polymerase (POLRMT) inhibitor. IMT1 causes a conformational change of POLRMT, which blocks substrate binding and transcription in a dose-dependent way in vitro. IMT1

IMT1 is a first-in-class specific and noncompetitive human mitochondrial RNA polymerase (POLRMT) inhibitor. IMT1 causes a conformational change of POLRMT, which blocks substrate binding and transcription in a dose-dependent way in vitro. IMT1

IMT1 is a first-in-class specific and noncompetitive human mitochondrial RNA polymerase (POLRMT) inhibitor. IMT1 causes a conformational change of POLRMT, which blocks substrate binding and transcription in a dose-dependent way in vitro. IMT1

IMT1 is a first-in-class specific and noncompetitive human mitochondrial RNA polymerase (POLRMT) inhibitor. IMT1 causes a conformational change of POLRMT, which blocks substrate binding and transcription in a dose-dependent way in vitro. IMT1

IMT1 is a first-in-class specific and noncompetitive human mitochondrial RNA polymerase (POLRMT) inhibitor. IMT1 causes a conformational change of POLRMT, which blocks substrate binding and transcription in a dose-dependent way in vitro. IMT1

IMT1 is a first-in-class specific and noncompetitive human mitochondrial RNA polymerase (POLRMT) inhibitor. IMT1 causes a conformational change of POLRMT, which blocks substrate binding and transcription in a dose-dependent way in vitro. IMT1